Atlas Trials

COVID-19 Antibody Responses in Cystic Fibrosis (CAR-CF)

Clinical trial NCT05217784 · UNKNOWN

Trial details

NCT number
NCT05217784
Sponsor
Rabin Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Cystic FibrosisCovid19
Start date
2022-01-25
Primary completion
2024-01-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.